Reports
Sale
Global Gabapentin Market Size, Share, Price, Forecast: By Product Type: Capsule, Tablet; By Application: Epilepsy, Neuropathic Pain, Restless Legs Syndrome; By Route of Administration: Oral, Parenteral, Intravenous; By Distribution Channel: Hospital Pharmacies, Other Distribution Channels; Regional Analysis; Supplier Landscape; 2024-2032
Global Gabapentin Market Outlook
The global gabapentin market size was valued at USD 2.10 billion in 2023, driven by the increasing use of gabapentin as a pain reliever drug across the globe. The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to achieve a value of USD 3.26 billion by 2032.
Gabapentin: Introduction
Gabapentin tablets, capsules, and oral solutions are used to control seizures of certain type by combining them with other medications. They are also used as a pain reliever for postherpetic neuralgia that are basically the sensations or body aches occurring after person has had a shingle attack. It is also used to endure the pain of diabetic neuropathies and hot flashes in women who are undergoing treatment for breast cancer or the ones that have had their menopause.
Global Gabapentin Market Analysis
The major factors aiding the market growth are the undergoing development of new formulation for gabapentin in order to enhance efficacy and adherence of patient in the gabapentin market. The growing evidence of research towards the use of gabapentin to reduce alcohol dependence could possibly contribute to the expansion of the market. The escalating adoption of telemedicine, exploration of combination therapies is among some other key trends propelling the global gabapentin market expansion.
Additionally, the increased off-label prescription of gabapentin for conditions such as anxiety disorders, insomnia, and fibromyalgia, among others is also driving the demand for gabapentin. Due to the increasing geriatric population and lifestyle changes, the prevalence of chronic pain conditions such as neuropathic pain, postherpetic neuralgia, and diabetic neuropathy has also increased, owing to the market growth as gabapentin is the main prescribed drug for the treatment of such conditions. Because of its well-known opioid-sparing properties, gabapentin can be used to treat pain along with less potent opioids.
Gabapentin can potentially treat several anxiety disorders such as bipolar disorder, and other mental health conditions, which is why it has gained attention in the market. The growing emphasis on mental health and the need for effective pharmacological interventions are directly contributing to the global gabapentin market development.
Global Gabapentin Market Segmentations
Market Breakup by Product Type
- Capsule
- Tablet
Market Breakup by Application
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
Market Breakup by Route of Administration
- Oral
- Parenteral
- Intravenous
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channels
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Gabapentin Market Overview
There are several major factors that are driving the market growth such as the increasing use of gabapentin as a pain reliever drug in the market. The rising incidence of chronic pains as shingles, diabetic neuropathy, and other pains that are hard to cure with the use of basic medicines are also contributing to the market growth.
Additionally, escalating demand for generic drug development which is comparatively less expensive than the drugs that are undersigned with name of big brands is propelling the growth of the market. Some other factors driving the market growth include the affordability and availability of Gabapentin in countries that are still developing with reasonable healthcare budgets. Gabapentin is available in different form as topical gels, oral solutions, capsules, tablets, and creams, and this factor is also a major driver for the gabapentin market growth. The increase in research and development to find new applications of gabapentin and develop new formulations to enhance the efficacy is a driver owing to the market growth.
Gabapentin has also been available in generic forms, which in turn is increasing competition among generic manufacturers. This competition would probably lead to lower prices and increased availability of gabapentin, driving market growth.
Gabapentin Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Zydus Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Sun Pharmaceutical Industries Ltd.
- Ascend Laboratories, LLC
- Apotex Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma.
- Amneal Pharmaceuticals LLC.
- Cipla
- Pfizer Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Gabapentin Market Overview
3.1 Global Gabapentin Market Historical Value (2017-2023)
3.2 Global Gabapentin Market Forecast Value (2024-2032)
4 Global Gabapentin Market Landscape
4.1 Image Guided Surgery: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Image Guided Surgery: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Route of Administration
5 Global Gabapentin Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Gabapentin Market Segmentation
6.1 Global Gabapentin Market by Product Type
6.1.1 Market Overview
6.1.2 Capsule
6.1.3 Tablet
6.2 Global Gabapentin Market by Application
6.2.1 Market Overview
6.2.2 Epilepsy
6.2.3 Neuropathic Pain
6.2.4 Restless Legs Syndrome
6.3 Global Gabapentin Market by Route of Administration
6.3.1 Market Overview
6.3.2 Oral
6.3.3 Parenteral
6.3.4 Intravenous
6.4 Global Gabapentin Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Hospital Pharmacies
6.4.3 Retail Pharmacies
6.4.4 Other Distribution Channels
6.5 Global Gabapentin Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Gabapentin Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Gabapentin Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Gabapentin Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Gabapentin Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Gabapentin Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Zydus Pharmaceuticals, Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Glenmark Pharmaceuticals Limited
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Sun Pharmaceutical Industries Ltd.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Ascend Laboratories, LLC
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Apotex Inc.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Teva Pharmaceutical Industries Ltd.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Aurobindo Pharma.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Amneal Pharmaceuticals LLC.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Cipla
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Pfizer Inc.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 2.10 billion in 2023 driven by the increasing use of gabapentin.
The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032, likely to reach a market value of USD 3.26 billion by 2032.
The escalating demand for generic drug development is major driver contributing to the market growth.
The escalating adoption of telemedicine in the market is a major trend driving the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The different types of products in the market include capsule and tablets.
It finds wide application in epilepsy, neuropathic pain, and restless legs syndrome treatments.
The routes of administrations of gabapentin include oral, parenteral, intravenous.
The different channels of distribution in the market include hospital pharmacies, retail pharmacies, among other distribution channels.
Key players involved in the market are Inc., Glenmark, Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Ascend Laboratories, LLC, Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma., Amneal Pharmaceuticals LLC., Cipla, Pfizer Inc., and Zydus Pharmaceuticals.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER